"Radiopharmaceuticals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)
Descriptor ID |
D019275
|
MeSH Number(s) |
D27.505.259.843 D27.505.519.871 D27.720.470.410.650
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Radiopharmaceuticals".
Below are MeSH descriptors whose meaning is more specific than "Radiopharmaceuticals".
This graph shows the total number of publications written about "Radiopharmaceuticals" by people in this website by year, and whether "Radiopharmaceuticals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1996 | 1 | 1 | 2 |
1997 | 2 | 1 | 3 |
1998 | 5 | 2 | 7 |
1999 | 9 | 3 | 12 |
2000 | 11 | 8 | 19 |
2001 | 9 | 7 | 16 |
2002 | 7 | 11 | 18 |
2003 | 8 | 13 | 21 |
2004 | 9 | 24 | 33 |
2005 | 7 | 16 | 23 |
2006 | 13 | 19 | 32 |
2007 | 9 | 19 | 28 |
2008 | 3 | 26 | 29 |
2009 | 13 | 15 | 28 |
2010 | 10 | 16 | 26 |
2011 | 10 | 16 | 26 |
2012 | 4 | 16 | 20 |
2013 | 8 | 27 | 35 |
2014 | 8 | 36 | 44 |
2015 | 17 | 21 | 38 |
2016 | 8 | 15 | 23 |
2017 | 9 | 18 | 27 |
2018 | 6 | 11 | 17 |
2019 | 6 | 17 | 23 |
2020 | 4 | 15 | 19 |
2021 | 7 | 14 | 21 |
2022 | 1 | 10 | 11 |
2023 | 1 | 7 | 8 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiopharmaceuticals" by people in Profiles.
-
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma. Clin Cancer Res. 2024 02 16; 30(4):680-686.
-
[18F]pFBC, a Covalent CLIP-Tag Radiotracer for Detection of Viral Reporter Gene Transfer in the Murine Brain. Bioconjug Chem. 2024 02 21; 35(2):254-264.
-
Parathyroid carcinoma: Imaging features of initial presentation and recurrence. A single center experience. Neuroradiol J. 2024 Feb; 37(1):92-106.
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
-
Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery. Mol Imaging Biol. 2023 Dec; 25(6):991-1019.
-
Molecular Breast Imaging and Positron Emission Mammography. PET Clin. 2023 Oct; 18(4):487-501.
-
Peritumoral Lidocaine Injection: A Low-Cost, Easily Implemented Intervention to Improve Outcomes in Early-Stage Breast Cancer. J Clin Oncol. 2023 06 20; 41(18):3287-3290.
-
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging. Nucl Med Biol. 2023 May-Jun; 120-121:108337.
-
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study. Br J Haematol. 2023 06; 201(6):1192-1199.
-
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence. Curr Opin Oncol. 2023 05 01; 35(3):231-238.